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Abstract
Individuals with serious mental illness (SMI) experience a notably
decreased life span due, in part to a metabolic syndrome linked
to psychotropic medications commonly prescribed to SMI patients.
Eli Lilly’s Solutions for Wellness (SFW) program was designed to
address some of the risk factors (e.g., weight, diet, lifestyle) that
exacerbate the metabolic syndrome in SMI outpatients. However,
there is limited data as to the effectiveness of the SFW program
for hospitalized SMI patients. We replicate and compare SFW
outcomes from an inpatient SMI population treated at the Utah
State Hospital with previous research that tested an abbreviated
SFW curriculum of eight lessons in a similar clinical population.
Primary outcomes include changes in weight and body mass index
(BMI) for 127 SMI patients. Factors that might explain outcome
differences included gender, age, diet, medication profile are
explored.

Keywords
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Introduction
Individuals with a severe mental illness experience a welldocumented decrease in life span. Parks, Svendsen, Singer, and Foti
determined that individuals with a serious mental illness (SMI) die an
average of 25 years younger than the general population [1]. Disease
and lifestyle choices are a primary cause of this excess mortality [2].
Although obesity is a considerable national health epidemic in the
United States general population, the rates for obesity in the SMI
population are considerably higher (42% vs. 27%) [2,3]. Research
literature also suggests that SMI, such as schizophrenia, serve as a risk
factor for metabolic syndrome even in antipsychotic naïve patients.
Jacob and Chowdhury discovered that individuals under the age 55
years with schizophrenia are four times more likely to have metabolic
syndrome and twice as likely to die from cardiovascular disease as the
general population [4]. In addition to an inherently increased risk
for metabolic danger, the use of nearly any antipsychotic medication
can contribute to increased weight gain which, in turn, increases
potential metabolic sequel [3,5,6].
Several known contributors to early death in this population
are modifiable, such as obesity, tobacco use, sedentary lifestyle,

ClinMed
International Library

and unhealthy diet choices. Increased risk of metabolic syndrome,
diabetes, and cardiac disease also significantly contribute to these
mortality rates. The Substance Abuse and Mental Health Services
Administration (SAMHSA) and Health Resources Services
Administration (HRSA) point out that this decreased lifespan is
“among the greatest health disparities experienced by any subgroup
in the United States” [7].
Research has also shown that weight management successfully
decreases the risk of diabetes, cardiac disease, and other metabolic
related health complications. Overweight and obese individuals
experience health benefits with as little as a 3-5% weight loss [8,9].
Weight loss programs are widely available to the general population
and include options like Weight Watchers, Jenny Craig, Slim
Fast, Atkins, and other diets. Research findings show that these
interventions can result in statistically significant weight loss. This,
in turn, decreases risk for weight-associated medical complications
and diseases [10].
The National Association of State Mental Health Program
Directors (NASMHPD) Medical Directors Council outlines suggested
standards of care to address this health concern. These suggestions
include classifying the problem as a priority health disparity,
building on SAMHSA evidence-based practices on healthy lifestyles,
promoting integrated mental and physical healthcare, implementing
standards of care for prevention, screening, and treatment [1].
Nurses are in an advantageous position to provide
psychoeducational group interventions, as well as information to
promote healthier lifestyle choices. The theoretical under pinnings
of psychoeducational groups is that the information provided lead to
behavior and symptom change and there is ample empirical evidence
in the group literature to empirically support this theoretical
assumption [11,12]. Eli Lilly’s Solutions for Wellness (SFW) is one
example of manualized group interventions that are designed to
provide education towards healthy lifestyle choices in individuals
with SMI [13,14]. The program began in 1998 and has undergone
several revisions [15]. One study focusing on SFW effectiveness from
over 7,000 program completers reported a mean weight change of
-4.5 kg for those who lost weight and +4.2 kg for those who gained
weight. Individuals who completed the program lost an average of
2.77 kg [16]. The SFW program is included in the SAMHSA National
Registry of Evidence-Based Programs and Practices (NREPP), which
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Table 1: Summary of SFW nutrition and physical activity lesson plans.
SFW – Nutrition Lessons

SFW – Physical Activity Lessons

1. Choosing Healthy Eating and Wellness

1. Mental Illness, Mental Health, and Physical Activity

2. A Small Changes Approach to Healthier Eating

2. Step Into Better Health

3. Food and Our Environment

3. Physical Activity and Our Environment

4. Benefits and Barriers of Healthy Eating

4. How Physically Active Are We?

5. Healthy Eating and Wellness Self-Assessment

5. The Benefits and Barriers of Being Physically Active: Part I

6. What Kind of Hungry Are You?

6. The Benefits and Barriers of Being Physically Active: Part II

7. Get the Facts: Nutrition Knowledge is Power

7. Fitness Self-Assessment and Goal Setting

8. Dietary Guidelines for Americans

8. Creating Balance

9. Adequate Nutrition within Calorie Needs: What Do the Guidelines Say?

9. Step Out of Stress

10. Food Groups to Encourage: What Do the Guidelines Say?

10. Physical Activity and Safety

11. Weight Management Part I: What Do the Guidelines Say?

11. Fitting Physical Activity into Your Daily Routine

12. Weight Management Part II: What Do the Guidelines Say?

12. What to Choose: Different Types of Physical Activities

13. Managing Stress Wisely

13. Aerobic Exercise

14. Portions and Servings: Know How Much You’re Eating

14. Flexibility Exercise

15. Strategies to Improve Eating Habits

15. Strengthening Exercise

16. Carbohydrates: What Do the Guidelines Say?

16. Tobacco and Your Health

17. Alcoholic and Non-alcoholic Drinks: What do the Guidelines Say?

17. Staying on the Road to a Healthier You

18. Tips for Eating Wisely on a Limited Budget
19. Food Safety: What do the Guidelines Say?
20. Fats: What do the Guidelines Say?
21. Salt (Sodium) and Potassium: What do the Guidelines Say?
22. Staying on the Road to a Healthier You

gave the program an overall 3.3 readiness for dissemination rating
(on a scale of 0.0-4.0) [17].

and limited information in regards to medication interventions [7].
We attempted to incorporated these suggestions herein.

SFW is structured for use with outpatient participants. Our
application relied upon the 3rd Edition of SFW which consists
of 22 nutrition lessons, and 18 physical activity lessons. Other
adaptations in the literature range from a 4 week/8 lesson AcuteSFW format to 10, 12, and 36 week formats. This study tested
both an abbreviated and full SFW nutrition and physical activity
curriculum, delivered in 45 minute weekly groups summarized in
table 1. This article evaluates the outcomes experienced by 127
inpatients attending the SFW groups led by registered nurses at
state psychiatric hospital. Specifically, we aimed to answer four
research questions: (1) Did SFW work statistically? (2) Did SFW
work clinically? (3) How did patients’ medication class effect
outcomes? And (4) What other moderators predict patient
outcomes?

Methods

Intervention
USH began offering the SFW program to patients at the Treatment
Mall in an effort to provide education to allow participants to make
health-improving choices. These choices, in turn, could potentially
lead to decreased risks of metabolic syndrome and associated
healthcare complications. Limited literature exists regarding program
outcomes on psychiatric in patients since SFW’s was designed to be
used with an outpatient population. Only one article studied a similar
population using an abbreviated SFW curriculum, Acute Solutions for
Wellness. More specifically, it was applied to an inpatient population
and offered as an 8 week group intervention that consisted of the
following lessons: Healthy Living, Physical Activity, Food Pyramid,
Food Servings, Fat & Salt, Healthy and Unhealthy Eating Habits,
High Fiber Diet and Controlling Your Hunger [18]. Overall, results
from this previous study did not demonstrate statistically significant
weight loss; participants experienced a mean weight gain of 0.26 kg
weight gain (SD = 2.02; median = 0 kg). Weight loss or maintenance
was reported in 33 of their 46 patients. The authors identified several
limiting factors, including small sample size and reduced program
length.
The current study takes into consideration the factors that
SAMHSA-HRSA (2012) identified as frequently overlooked when
interpreting and applying lifestyle interventions for the SMI
population [19]. Common limitations include relatively small sample
sizes, limited information on gender, lack of information regarding
proportion of individuals experiencing significant weight change,
King et al. Int Arch Nurs Health Care 2016, 2:055

Participants
Participants were selected from the English speaking population
receiving treatment at USH- a 24 hour inpatient psychiatric facility
for patients with severe and persistent mental illnesses. The study
was not funded, but was approved by the Utah State Department of
Human Services Institutional Review Board. Informed consent was
not obtained because participation in this study involved attending a
regularly offered group and was considered treatment as usual.
When the study began, USH had five adult civil units and one
geriatric unit with an average of 30 beds per unit. During the study,
one adult civil unit was closed. In addition, USH has four forensic
units and 3 pediatric units which were not part of this study. Illnesses
treated at the hospital include psychotic, substance abuse, mood,
cognitive, eating, personality, and childhood disorders. A breakdown
of 483 patient diagnoses being treated during the study period was
22% anxiety, 20% schizophrenia, 17% schizoaffective, 14% major
depression, 11% for bipolar disorder, 4% other psychotic disorders,
and 13% other Axis I diagnoses.
In order to recruit participants, class information was sent to all
treatment teams for the adult civil units and referrals were made by
treatment teams in each unit. The announcement included the target
population, proposed schedule, and objectives for each group session.

Treatment
SFW groups were held at a Treatment Mall, and participants were
recruited from the English speaking, adult, civil patient population
at USH. Group information, including the name and topic of the
group, as well as recommended inclusion criteria were sent to the
treatment teams for all adult patients. Treatment teams consisted
of psychiatrists, administrative directors, unit nursing directors,
and social workers. Recommended inclusion criteria from Eli Lilly’s
manual:

•
•

Body mass index (BMI) ≥ 30 OR

•

2 or more risk factors (disease conditions, other obesity-associated
diseases, and/or cardiovascular disease risk factors)

BMI ≥ 25-29.9 or high waist circumference (> 40” men/> 35”
women) &
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Table 2: Common psychotropic medication ordered by risk of weight gain.
Low Risk

Moderate Risk

High Risk

Aripiprazole

Chlorpromazine

Clozapine

Asenapine

Risperidone

Olanzapine

Haloperidol

Lurasidone

Quetiapine

Ziprasidone
Paliperidone
Fluphenazine

Participants consisted of those whose treatment teams referred
and those who requested to attend the program. Patient weights were
measured on their treatment units monthly. BMI is automatically
calculated by the USH electronic charting system-E-chart. Hospital
protocol requires patient weight and vital signs be recorded in E-chart
monthly, unless ordered more frequently. The weight and BMI data
collected for this study came from E-chart entries that aligned with
the time frame that the patient was in the Solutions for Wellness
Group. The researchers also collected E-chart information relating to
a patient’s psychiatric medications, and whether the patient was on a
regular or a prescribed diet (heart healthy, carb controlled, etc).
Groups consisted of weekly 45 minute classes and the Eli Lilly’s
Solutions for Wellness structured outline was followed for each
group, which included: welcoming group participants, reviewing the
previous weeks main learning points, reviewing the previous weeks
small step goal, introduction of new material, pre-quiz, new lesson
material, review, and each member choosing a new weekly small step
goal. Groups were initially set to a nine week duration to parallel
the Bushe, et al. abbreviated lesson format [18]. The most pertinent
lessons were selected; 1, 2, 3, 4, 5, 10, 11, 12, and 13 of the Healthy
Eating curriculum. However, no significant weight loss was found.
Based upon SAMHSHA-HRSA’s recommendations that program
interventions lasting longer than three months are more effective, we
transitioned to the full 39 lesson SFW Nutrition and Physical Activity
plan described in table 1. Groups had an average of 13 patients per
group and an average attendance rate of 50%. Reasons for missed
groups included other appointments, trial leaves, medical illness, or
unit restriction [19].

Analysis
Due to gaps in treatment, patient data was first broken out into
discrete episodes. An episode of treatment was defined as continuous
participation in SFW group with no gaps in treatment longer than
four weeks. This practice is consistent with hospital practice to
drop a patient from a group after three consecutive weeks of missed
treatment. Patients who had been dropped from group could later
be re-enrolled when referred by their treatment team. Two separate
analyses were conducted- one using all patient data, and one using
first treatment episode data.
The outcome measure of interest in the present study was
changes in weight, measured before and after the SFW intervention.
To investigate question 1, whether the program was statistically
successful, a paired sample t-test was performed comparing patients’
pre- and post-treatment weights. If patient data included a gap
in treatment greater than four weeks, analysis was performed on
the first discrete episode of treatment. This practice was meant to
prevent patient data from being examined multiple times within the
same analysis. Results are reported excluding one extreme outlier,
bringing the total N to 114. In order to examine question 2, whether
the program was clinically successful, patients who had experienced
clinically significant weight change were identified- which previous
literature established as a 5% change in weight from pre to post [9].
The percent of patients that experienced clinically significant weight
loss was then calculated.
As previous research has found that individuals on high risk
medication that participated in the Solutions for Wellness intervention
maintained their weight without losing or gaining weight, question
3 evaluated the effect of medication class. This was done through a
one-way analysis of variance (ANOVA), with weight change pre- to
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post-treatment as the dependent variable and medication class as
the factor. Patient psychiatric medication profiles were taken into
account using the recent literature on weight gain risk associated with
psychotropic medications, and three categories of medication risk
were created (Table 2) [3,6,20]. Finally, in order to answer question
4, what other moderators predict weight change, a regression analysis
was performed with medication category, starting weight, sessions
attended, gender, age, and prescribed diet as predictor variables and
weight change as the dependent variable. SPSS Version 21 was used
for all analyses.

Results
Treatment was administered to 127 patients at USH, but 11 of
those patients were excluded from analyses due to lack of recorded
post-treatment weight and BMI. These patients (54 males, 62 females)
had a mean age of 38.25 (17- 69, SD = 11.0). The average starting
weight was 200.25 (112- 449, SD = 55.11), and the average starting
BMI was 31.42 (16.5- 62.6, SD = 8.39). Twenty-five (21.6%) of the
patients were either taking no antipsychotic medication or a low risk
of weight gain medication, 21 (18.1%) of patients were on a medium
risk of weight gain medication, and 70 (60.3%) of patients were on
a high risk of weight gain medication. Of the 116 patients included
in the analysis, 89 started in the obese or overweight category.
Before analyses were performed, patient data was first broken in to
distinct episodes of treatment. A total of 131 episodes resulted from
the116 program participants. Results were similar when analyzing all
episodes and first episodes only for each client, and results for first
episode only are reported below.

Did lilly work statistically?
Overall, the patients lost an average of 0.86 lbs. (42.8 lb. loss- 23.6
lb. gain, SD = 10.22) over the course of the SFW treatment. A paired
sample T-test revealed no statistically significant change between
starting and ending weight, t (113) = 0.90, p = 0.37.

Did lilly work clinically?
Of the 88 (77.2%) patients that started in the overweight or obese
BMI category, 12 of those patients (10.5%) experienced clinically
significant weight loss, 16 (14%) experienced clinically significant
weight gain, and the remaining 86 (75.4%) did not experience a
clinically significant weight change. On average, the patients gained
0.02% of their body weight (SD = 4.94).

How did patients’ medication class effect patient outcomes?
As a primary moderator of interest, the effect of medication
class on weight change was examined. An ANOVA showed that
weight change differed by medication category, F(2,111) = 5.23, p =
0.007- with the no medication/low risk med class losing 6.33 lbs., the
medium risk medication class gaining 0.3 lbs., and the high risk med
class gaining 0.91 lbs.

What other moderators predict patient outcomes?
In addition to medication, several secondary moderators of
weight change were also examined using a linear regression. These
included starting weight, sessions attended, gender, age, and diet. Of
these secondary moderators, starting weight significantly predicted
weight change (Β = -0.32, p = 0.002), such that a higher starting
weight was associated with greater weight loss. Medication class was
not found to be significant after controlling for the other variables.
Gender, age, and diet were not found to be significant predictors of
weight loss.

Discussion
Both SAMHSA and NASMHPD have flagged the SMI decreased
life span and metabolic syndrome as serious health concerns that
must be addressed. Our study initially replicated one of the few SMI
inpatient applications of the abbreviated Solution for Wellness group
program and like Bushe and colleagues, we found no statistically
significant weight loss [18]. The primary focus of our study was an
ISSN: 2469-5823
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implementation of the full 39 lesson SFW program in daily practice
with a SMI inpatient sample size that more than doubled the Bushe,
et al. investigation [18]. This longer intervention addressed one of
SAMHSA-HRSA (2012) limitations of past SMI research [19]. We
addressed additional limitations by noting the proportion of patients
who gained, lost or maintained weight and exploring potential
moderators raised in the literature; beginning weight, sessions
attended, gender, age and diet. Finally, we explored the interaction of
weight loss/by with medication class.
Application of the full SFW intervention produced the same lack
of statistical change noted by Bushe, et al. when patients were tested
as a group [18]. A portion of the sample lost (10.5%) or gained (14%)
weight, so, we explored this variability and found that the medication
a patient was taking was associated with final weight status. The
average patient in the low risk category lost over 6 pounds compared
to an average weight gain of 1 pound in the high risk category. At face
value, these findings support past research that has shown differential
effects of psychotropic medication on weight gain [3,6,20]. Stated
differently, SMI inpatients whose medication profile falls in our low
risk category may benefit from the full SFW group intervention.
Our replication of the Bushe, et al. findings for the abbreviated
SFW intervention suggests that 8-9 sessions may be insufficient to
achieve significant weight loss with SMI inpatients. Moreover, our
findings extend beyond the Bushe, et al. study by connecting length
of treatment and medication profile of SMI inpatients to successful
weight loss replicating Litrell, et al. findings [18,21]. While based
upon a much larger sample than Bush et al. These findings must be
replicated with similar samples before our conclusions are accepted
and applied in practice [18]. Additionally, high risk patients in the
present study were referred to the SFW program and not randomly
assigned. Future research should examine the effects of SFW in a
randomized controlled trial format.
We also included a moderator analysis to determine if the
variability in weight loss could be explained by starting weight,
sessions attended, gender, age and diet. The only variable that was
significantly related to weight change was starting weight which
replicates a general finding in the weight loss literature. Thus, better
candidates for programs such as the SFW group intervention may
be those who exceed normative weight expectations. Interestingly,
in our study the significance of medication class disappeared after
starting weight was entered into our linear regression equation. Since
this is one of the first studies we could locate that focused upon an
SMI inpatient population, we’re unclear on the clinical implications
of this finding. It may be that both starting weight and medication
class matter but that our sample was too small to sufficient power
statistical detection of both. On the other hand, there may be an
interaction between starting weight and medication class (i.e.,
multicollinearity) such that the former (starting weight) contains
enough common variance with medication class that it drops out as
a significant predictor. Given the preliminary nature of this finding it
too awaits further study and replication.

Conclusion
In conclusion, our findings when coupled with Bushe, et al.,
suggest that the abbreviated SFW group intervention is ineffective
for SMI inpatients [18]. This finding is in agreement with past
recommendations regarding treatment length for SMI patients
[19]. However, modest weight loss success may result when the full
39-session SFW program is applied to SMI in patients who are in the
low risk psychotropic class or whose starting weight is higher than
the average patient. These findings are limited by the average group
attendance observed in our study (50%), the medications represented
in our patient population, the population treated at USH, and
unknown leader factors that may affect treatment success.
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